microRNAs in the Malignant Transformation Process
- 1 January 2015
- book chapter
- Published by Springer Nature
- Vol. 889, 1-21
Abstract
Many cancers originate as benign neoplasms that transform into malignant cancerous tumors in a multistep progression that is regulated, in part, by microRNAs. Benign neoplasms, by definition, lack the ability to invade adjacent tissues or spread to distant sites through metastasis. The benign to malignant transition is a critical intervention stage as tumors diagnosed in subsequent nonlocalized and malignant stages are exponentially more difficult to treat successfully. This chapter explores the critical roles that microRNAs play in the transformation from benign to malignant in four representative cancers: colorectal cancer, pancreatic cancer, malignant peripheral nerve sheath tumor, and prostate cancer. Understanding how these microRNAs control this progression and transformation will lead to new therapeutic targets and diagnostic biomarkers, resulting in improved treatments and patient outcomes.Keywords
This publication has 134 references indexed in Scilit:
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Secreted microRNAs: a new form of intercellular communicationTrends in Cell Biology, 2012
- Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screeningBritish Journal of Cancer, 2010
- MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progressionBritish Journal of Cancer, 2009
- Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone MarrowCell, 2008
- Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancerOncogene, 2008
- Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analysesBritish Journal of Cancer, 2008
- Expression profiling identifies microRNA signature in pancreatic cancerInternational Journal of Cancer, 2006
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005